AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2026

Jan 27, 2026

34412_dirs_2026-01-27_92615c49-ac92-4d40-9a44-53c3f5b3c46d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2026-01-24

Reporting Person: Healey Don (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-01-24	Common Stock	F	535	$8.44	Disposed	3452	Direct

Footnotes

F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units and does not represent a sale by the Reporting Person.

F2: Reflects a 1-for-16 reverse stock split effected by the Issuer on December 30, 2025.